Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Teijin licenses new thrombolytic from Schering AG

Nov. 5, 1997

Factor Xa inhibitors prepared at DuPont Merck

Nov. 4, 1997

New orally active thrombin inhibitors from Merck & Co.

Nov. 3, 1997

Ortho discloses peptide serine protease inhibitors

Oct. 30, 1997

Advisory committee recommends approval for Plavix

Oct. 29, 1997

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Oct. 29, 1997

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Patents issued to Corvas for serine protease inhibitors

Oct. 22, 1997

Gensia receives FDA approval for desmopressin acetate injection

Oct. 21, 1997

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...